The Foreign-Trade Zones Board issued the following notices on Oct. 28:
The Office of the U.S. Trade Representative is seeking applications from Native Americans, Native Hawaiians and Native Alaskans who want to serve as an indigenous peoples' representative on the observer delegation to the Partnership Council of the Indigenous Peoples Economic and Trade Cooperation Arrangement. Applications for the two-year terms are due by Dec. 6 at 5 p.m. EST. Applications should be sent to mbx.ustr.iape@ustr.eop.gov.
Rep. Jimmy Panetta, D-Calif., issued a release Oct. 25 asking his colleagues to change the law so that Kazakhstan can receive permanent normal trade relations, as Kyrgyzstan, Georgia and other former Soviet states do. Kazakhstan goods are subject to Column 1 tariffs, but that status must be renewed annually.
The Commerce Department has the authority to countervail currency undervaluation, the Court of International Trade held in a decision made public Oct. 25. Judge Timothy Reif found that nothing in the text of the countervailing duty statute, the statute's legislative history or legislative or administrative developments prohibit Commerce from imposing CVD due to a country's undervalued currency.
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website Oct. 25, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP issued the following releases on commercial trade and related matters:
CBP recently held that a teleprompter base is properly classified as an article of aluminum rather than as a part of an electrical machine, upholding an August 2022 ruling after an importer requested reconsideration.
Matt Cronin, former chief investigative counsel for the House Select Committee on China, has joined venture capital firm Andreessen Horowitz as a senior national security adviser, he announced on LinkedIn. He left his job on Capitol Hill earlier this month (2410160022).
The Drug Enforcement Administration is permanently placing the synthetic benzimidazole-opioids butonitazene, flunitazene and metodesnitazene in Schedule I of the Controlled Substances Act, it said in a final rule. The substances had already been temporarily listed in Schedule I since 2022 (see 2204110029). The final rule takes effect Oct. 25.
The International Trade Commission published notices in the Oct. 25 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):